研究成果Research Output

1.通过检测人胸苷激酶1的浓度发现不可见的恶性肿瘤《欧洲细胞生物学杂志》

Zhou, J., Li, H., Fang, C., Gao, P., Jin, C., Liu, S., Zou, R., Li, J., Liu, Y., He, E., & Skog, S. (2022). Concentration of human thymidine kinase 1 discover invisible malignant human tumours. European journal of cell biology101(4), 151280. https://doi.org/10.1016/j.ejcb.2022.151280



2.针对SARS-CoV-2蛋白质组芯片鉴定的17种有效保守肽的新型中和鸡IgY抗体及其未来展望 《免疫学前言》

Li, J., Liang, T., Hei, A., Wang, X., Li, H., Yu, X., Zhao, R., Gao, P., Fang, C., Zhou, J., Li, M., He, E., & Skog, S. (2022). Novel neutralizing chicken IgY antibodies targeting 17 potent conserved peptides identified by SARS-CoV-2 proteome microarray, and future prospects. Frontiers in immunology13, 1074077. https://doi.org/10.3389/fimmu.2022.1074077



3.血清胸苷激酶1是结直肠癌的原发肿瘤位置的预后生物标志物吗?《肿瘤学.发现》

Fang, Y., Skog, S., Ou, Q., Chen, Z., Liu, S., Hei, A., Li, J., Zhou, J., He, E., & Wan, D. (2023). Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?. Discover. Oncology14(1), 21. https://doi.org/10.1007/s12672-023-00614-5



4.一种抗人胸苷激酶1的重组全长IgY单克隆抗体在生物素-链亲和素夹心平台用于肿瘤早期发现的自动化学发光分析《免疫学研究杂志》

Xiangbin Wang, Shan Li, Rui Zhao, Huijun Li, Peng Gao, Cuicui Jin, Cong Fang, Yongping Liu, Ailian Hei, Ji Zhou, Jin Li, Ellen He, Sven Skog. (2023). Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery. Journal of Immunology Research, 14. https://doi.org/10.1155/2023/7612566